« Previous
Next »
Fertility and Sterility
Volume 92, Issue 1
, Pages 137-142
, July 2009
The impact of rescue in vitro fertilization converted from high-response gonadotropin intrauterine insemination cycles in terms of implantation and pregnancy rates as compared with matched controls
References
- Prospective randomized trial comparing the outcome and cost of in vitro fertilization with that of a traditional treatment algorithm as first-line therapy for couples with infertility. Fertil Steril. 1999;71:468–475
- . Cost-effectiveness of primary offer of IVF vs. primary offer of IUI followed by IVF (for IUI failures) in couples with unexplained or mild male factor subfertility. BMC Health Serv Res. 2006;6:80
- Efficacy of treatment for unexplained infertility. Fertil Steril. 1998;70:207–213
- . Factors responsible for multiple pregnancies after ovarian stimulation and intrauterine insemination with gonadotropins. J Assist Reprod Genet. 1996;13:663–668
- . Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006;12:651–671
- . Conversion of cycles involving ovarian hyperstimulation with intrauterine insemination to in-vitro fertilisation. Hum Reprod. 1994;9:406–408
- . Conversion of high-response gonadotropin intrauterine insemination cycles to in-vitro fertilization results in excellent ongoing pregnancy rates. Fertil Steril. 2002;77:715–722
- . Role of rescue IVF-ET treatment in the management of high response in stimulated IUI cycles. J Obstet Gynaecol. 2005;25:166–168
- . The use of gonadotrophin releasing hormone agonists for in vitro fertilization and other assisted procreation techniques: experience from three centres. Hum Reprod. 1992;7(Suppl 1):49–66
- . Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocol for in vitro fertilization. Fertil Steril. 1991;55:1157–1164
- . Mid-luteal endometrial intracrinology following controlled ovarian hyperstimulation involving use of a gonadotrophin releasing hormone antagonist. Hum Reprod. 2007;22:2981–2991
- . GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry. Hum Reprod. 2005;20:2373–2375
- . Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?. Fertil Steril. 2005;83:1607–1611
- . The hormonal control of endometrium receptivity: estrogen (E2) and progesterone. J Reprod Immunol. 1998;39:149–166
- . Controlled ovarian hyperstimulation does not adversely affect endometrial receptivity in in vitro fertilization cycles. Fertil Steril. 2001;76:670–674
- . Cost-effectiveness of a mild compared with a standard strategy for IVF: a randomized comparison using cumulative term live birth as the primary endpoint. Hum Reprod. 2008;23:316–323
- A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial. Lancet. 2007;369:743–749
- . Number of embryos for transfer after IVF and ICSI: a Cochrane review. Hum Reprod. 2005;20:2681–2687
- . Fertility: assessment and treatment for people with fertility problems. Clinical Guideline. London: RCOG Press; 2004;
B.H. has nothing to disclose. T.B. has nothing to disclose. E.S. has nothing to disclose. T.C. has nothing to disclose. C.O.H. has nothing to disclose. S.E. has nothing to disclose.
PII: S0015-0282(08)01233-8
doi: 10.1016/j.fertnstert.2008.05.077
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 92, Issue 1
, Pages 137-142
, July 2009

